Correct format of Audit report as per SEBI prescribed format (Refer SEBI Circular CIR/CFD/CMD1/80/2019 dated July 19, 2019 ) for the quarter and year ended on 31.03.2024
Awaiting price reaction for this filing.
Citurgia Biochemicals has resubmitted its audit report for the quarter and year ended 31 March 2024 to BSE in the format prescribed by SEBI circular CIR/CFD/CMD1/80/2019. This follows format-related queries raised by BSE on 15 April 2025 and 20 May 2025 on the earlier submission. The auditor, G.P. Keshri & Associates (FRN 017251N), issued an unmodified (clean) opinion stating the standalone financial results give a true and fair view. The results show a net loss for the quarter and the financial year ended 31 March 2024. The original audit report is dated 22 May 2024, while the resubmission letter to BSE is dated 22 May 2025.
This is primarily a procedural resubmission to address BSE's formatting queries rather than new financial information, so no fresh material impact on the stock is expected. However, the underlying audited results confirm the company reported a net loss in FY24, which remains a concern for shareholders. The clean audit opinion is mildly reassuring on the integrity of the reported numbers.